Comparative Indicators of Hormonal Changes in Women with Polycystic Ovary Syndrome Depending on Body Mass Index
DOI:
https://doi.org/10.31150/ajshr.v3i6.1160Keywords:
overweight, obesity, insulin resistance, hyperandrogenism, hormones, polycystic ovariesAbstract
Comparative indicators of hormonal changes in women with polycystic ovary syndrome depending on body mass index
References
Zawadski, JK.; Dunaif, A. Diagnostic criteria for polycystic ovary syndrome; towards a rationalapproach. In: Dunaif, A.; Givens, JR.; Haseltine, F., editors. Polycystic Ovary Syndrome. Vol. 1992. Boston, MA: Black-well Scientific; p. 377-384.
National Institutes of Health. Evidence-Based Methodology Workshop on Polycystic OvarySyndrome: Executive Summary. Washington: National Institutes of Health; 2012.
Azizova G.D., Asatova M.M., Nadyrkhanova N.S., Dauletova M.J. Polycystic Ovary Syndrome As A Predictor Of Metabolic Syndrome In Women Of Reproductive Age. Nat. Volatiles & Essent. Oils, 2021; 8(4): 15615-15618
Reinehr T, Kulle A, Rothermel J, et al. Longitudinal analyses of the steroid metabolome in obese PCOS girls with weight loss. Endocr Connect. 2017;6(4):213-224.
Moran C, Arriaga M, Arechavaleta-Velasco F, Moran S. Adrenal androgen excess and body mass index in polycystic ovary syndrome. J ClinEndocrinolMetab. 2015;100:c9999.
Pasquali R, Oriolo C. Obesity and androgens in women. Front Horm Res. 2019;53:120-134.1836.
Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467-520.
Ryazantseva E.M., Potin V.V., Tarasova M.A., Misharina E.V. The role of hyperleptinemia, insulin resistance and hyperestrogenemia in the development of ovarian insufficiency in women with obesity // Journal of Obstetrics and Women's Diseases. 2016; 65(5). Page 56-63.
Vembu R, Reddy NS. Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria and AMH. EndocrRev. 2017; 18(1): 17-21
